Estratab


Combined with:

Cycrin
Estrace
Premarin
Prempro
Provera

Indications and Reactions:

Role Indications Reactions
Secondary
Hormone Replacement Therapy 84.5%
Menopausal Symptoms 7.5%
Menopause 2.9%
Oestrogen Replacement Therapy 1.1%
Hypertension 0.8%
Hormone Therapy 0.4%
Depression 0.3%
Diabetes Mellitus 0.3%
Drug Use For Unknown Indication 0.3%
Thyroid Disorder 0.2%
Amnesia 0.2%
Blood Pressure 0.2%
Hot Flush 0.2%
Insomnia 0.2%
Night Sweats 0.2%
Blood Cholesterol Increased 0.2%
Cardiac Disorder 0.2%
Hypersensitivity 0.2%
Fluid Retention 0.1%
Heart Rate Irregular 0.1%
Breast Cancer Female 41.4%
Breast Cancer 40.9%
Breast Cancer Metastatic 7.1%
Breast Cancer In Situ 2.2%
Progesterone Receptor Assay Positive 1.7%
Cerebrovascular Accident 1.5%
Vascular Dementia 0.9%
Myocardial Infarction 0.6%
Cholecystitis Chronic 0.4%
Cholelithiasis 0.4%
Gallbladder Disorder 0.4%
Ovarian Cancer Metastatic 0.4%
Polytraumatism 0.4%
Uterine Leiomyoma 0.4%
Visual Disturbance 0.4%
Visual Impairment 0.4%
Breast Cancer Recurrent 0.2%
Contralateral Breast Cancer 0.2%
Deep Vein Thrombosis 0.2%
Depression 0.2%
Concomitant
Osteoporosis 16.1%
Antacid Therapy 9.7%
Drug Use For Unknown Indication 9.7%
Essential Tremor 8.1%
Hormone Replacement Therapy 8.1%
Metastases To Bone 6.5%
Arthritis 4.8%
Hypertension 4.8%
Rheumatoid Arthritis 4.8%
Tremor 4.8%
Asthma 3.2%
Osteopenia 3.2%
Pain 3.2%
Prostate Cancer 3.2%
Arthralgia 1.6%
Atrial Fibrillation 1.6%
Coronary Artery Bypass 1.6%
Diabetes Mellitus Non-insulin-dependent 1.6%
Hypomania 1.6%
Hypothyroidism 1.6%
Toothache 15.6%
Breast Cancer 9.4%
Tooth Disorder 9.4%
Pain 6.3%
Rheumatoid Arthritis 6.3%
Vitamin D Deficiency 6.3%
Wound 6.3%
Breast Cancer Metastatic 3.1%
Dyspnoea 3.1%
General Physical Health Deterioration 3.1%
Hypertension 3.1%
Pain In Extremity 3.1%
Palatal Disorder 3.1%
Psoriasis 3.1%
Quality Of Life Decreased 3.1%
Rash 3.1%
Trismus 3.1%
Urticaria 3.1%
Uterine Disorder 3.1%
Vomiting 3.1%

Drug Data